Indaptus Therapeutics (INDP) Other Accumulated Expenses (2020 - 2026)
Indaptus Therapeutics' Other Accumulated Expenses came in at $112,350 for Q1 2026, up 56.0% from $72,042 a year earlier.
Powered by 
Analysis
Indaptus Therapeutics (INDP) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Indaptus Therapeutics' Other Accumulated Expenses was $5,582, down 67.6% from FY2024.
- Other Accumulated Expenses has declined in each of the last four years, with a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $17,228 in FY2024 (-0.6%), $17,330 in FY2023 (-42.2%), $29,968 in FY2022 (-69.4%) and $97,779 in FY2021.
- The Q1 2026 figure represents the highest quarterly Other Accumulated Expenses since Q3 2021.
- Year-over-year, Other Accumulated Expenses increased in four of the last eight quarters, with growth averaging 20.2%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q1 2025 (growth of 175.9%), and the weakest in Q2 2022 (a decline of 99.3%).
- Business Quant data shows INDP's Other Accumulated Expenses at $5,582 (Q4 2025), $19,610 (Q3 2025) and $25,283 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Indaptus Therapeutics | 152.59 Mn | 125.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 112,350.00 |
| Dec 31, 2025 | 5,582.00 |
| Sep 30, 2025 | 19,610.00 |
| Jun 30, 2025 | 25,283.00 |
| Mar 31, 2025 | 72,042.00 |
| Dec 31, 2024 | 17,228.00 |
| Sep 30, 2024 | 22,449.00 |
| Jun 30, 2024 | 32,511.00 |
| Mar 31, 2024 | 26,110.00 |
| Dec 31, 2023 | 17,330.00 |
| Sep 30, 2023 | 19,963.00 |
| Jun 30, 2023 | 26,971.00 |
| Mar 31, 2023 | 19,484.00 |
| Dec 31, 2022 | 29,968.00 |
| Sep 30, 2022 | 61,945.00 |
| Jun 30, 2022 | 37,421.00 |
| Mar 31, 2022 | 58,340.00 |
| Dec 31, 2021 | 97,779.00 |
| Sep 30, 2021 | 355,514.00 |
| Jun 30, 2021 | 5.04 Mn |
API Access
Indaptus Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INDP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "INDP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INDP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();